BTCC
/
BTCC Square
/
Global Cryptocurrency
/
3 Absurdly Cheap Stocks Under $100 With Long-Term Potential
3 Absurdly Cheap Stocks Under $100 With Long-Term Potential
17
1
BTCCSquare news:
Novo Nordisk, Target, and Pfizer emerge as deeply undervalued equities trading below $100, presenting contrarian opportunities despite recent underperformance. The Danish pharmaceutical giant faces headwinds from compounded drug competition and revised guidance, yet maintains growth runway for flagship products Wegovy and Ozempic.
Market skepticism has compressed Novo Nordisk's valuation to $59 per share—a 32% year-to-date decline that belies the structural demand for GLP-1 therapies. Analysts note the weight-loss treatment segment remains underpenetrated globally, with expansion potential outweighing near-term supply constraints.
By:
